Korean Drug Co Ltd (014570) - Financial and Strategic SWOT Analysis Review



Korean Drug Co Ltd (KDC) is a pharmaceutical company that offers generic medicines. The company develops, manufactures and markets over the counter pharmaceutical products, ETC and health food products. Its over the counter products include allertec tablets, amiplex tablets, asno capsules, balad ointement, bebekin creams, caremore five solutions, clenbal solutions, click test, danzamin tablets, dermaclear gels, dube solutions, evervital softcapsules, and glucom solutions. KDC offers ETC products such as AD-med solution, ADmed tablet, betadien ointment, betavate cream, betavate solution, and betavate ointment. The company offers health food products which include calD-max tablet, kitten-max tablet, and zantrol mixed lactobacillus. It markets products in Incheon, Kyunggi, Pusan, Taegu, Daejeon, Gwangju, Jeonju and Gyoengnam, South Korea. KDC is headquartered in Icheon, South Korea.

This comprehensive SWOT profile of Korean Drug Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Korean Drug Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

Korean Drug Co Ltd - Key Information
Korean Drug Co Ltd - Overview
Korean Drug Co Ltd - Key Employees
Korean Drug Co Ltd - Key Employee Biographies
Korean Drug Co Ltd - Key Operational Heads
Korean Drug Co Ltd - Major Products and Services
Korean Drug Co Ltd - History
Korean Drug Co Ltd - Company Statement
Korean Drug Co Ltd - Locations And Subsidiaries
Korean Drug Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Korean Drug Co Ltd - Business Description
Korean Drug Co Ltd - Corporate Strategy
Korean Drug Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Korean Drug Co Ltd - Strengths
Korean Drug Co Ltd - Weaknesses
Korean Drug Co Ltd - Opportunities
Korean Drug Co Ltd - Threats
Korean Drug Co Ltd - Key Competitors

Section 3 - Company Financial Performance Charts

Korean Drug Co Ltd - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



Korean Drug Co Ltd, Key Information
Korean Drug Co Ltd, Key Ratios
Korean Drug Co Ltd, Share Data
Korean Drug Co Ltd, Major Products and Services
Korean Drug Co Ltd, History
Korean Drug Co Ltd, Key Employees
Korean Drug Co Ltd, Key Employee Biographies
Korean Drug Co Ltd, Key Operational Heads
Korean Drug Co Ltd, Other Locations
Korean Drug Co Ltd, Subsidiaries
Korean Drug Co Ltd, Key Competitors
Korean Drug Co Ltd, SWOT Analysis
Korean Drug Co Ltd, Ratios based on current share price
Korean Drug Co Ltd, Annual Ratios
Korean Drug Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



Korean Drug Co Ltd, Performance Chart
Korean Drug Co Ltd, Ratio Charts
 


Global Animal Drug Compounding Market Research Report 2021-2025

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Animal Drug Compounding Report by Material, Application, and Geography Global

USD 3200 View Report

2021 Leading Generic Drug Companies SWOT Analysis--Capabilities, Goals and Strategies

2021 Leading Generic Drug Companies SWOT Analysis--Capabilities, Goals and Strategies market research report available in single user pdf license with Aarkstore Enterprise at USD 4500

USD 4500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available